PD-L1 predicts chemotherapy resistance in large-cell neuroendocrine carcinoma

Br J Surg. 2023 Jun 12;110(7):749-752. doi: 10.1093/bjs/znac335.
No abstract available

MeSH terms

  • B7-H1 Antigen
  • Carcinoma, Neuroendocrine* / pathology
  • Humans
  • Lung Neoplasms* / pathology
  • Neuroendocrine Tumors* / pathology

Substances

  • B7-H1 Antigen